VALBY, Denmark, April 4, 2025 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) will present positive interim results from the open-label extension of the PACIFIC trial investigating bexicaserin, in addition to new analyses from clinical trials and real-world data with eptinezumab. H. Lundbeck...
Read More Details
Finally We wish PressBee provided you with enough information of ( Lundbeck to present positive pipeline data at American Academy of Neurology (AAN) Annual Meeting )
Also on site :
- ‘BBQ Brawl’ Shocker: Who Went Home After the Campfire Cowboy Feast Challenge?
- Today's Wordle Hint, Answer for 1472 on Monday, June 30, 2025
- Numbrix 9 - June 30